Taubman Emerging Scholar Johann Gudjonsson, M.D., Ph.D., receives prestigious research grant
Johann Gudjonsson, M.D., Ph.D., a Taubman Emerging Scholar and assistant professor of dermatology at the University of Michigan Medical school, is among 16 physician-scientists nationwide chosen to receive a prestigious research grant from the Doris Duke Charitable Foundation.
Dr. Gudjonsson will receive $486,000 over three years to continue his study of risk factors for psoriasis. The Doris Duke foundation grants align with the mission of the Taubman Institute's Emerging Scholars Program, which aims to encourage junior faculty to pursue research into new thrapies and cures in addition to clinical practice.
The Clinical Scientist Development Award (CSDA) provides funding for physician-scientists in the process of establishing their own research teams and enables them to secure 75 percent of their professional time for clinical research, the foundation said. This year’s awardees are conducting research in diverse areas, including childhood malnutrition, pancreatic cancer and rheumatoid arthritis.
“For the clinical research workforce to remain strong, we must invest in the next generation of researchers,” said Sindy Escobar-Alvarez, program officer for the Medical Research Program.
“Supporting young physician-scientists as they transition to independence is especially important as they must juggle the responsibilities of conducting research with seeing patients.”
Dr. Gudjonsson approaches the study of psoriasis and other inflammatory diseases at the genetic level, but also contributes to other novel research in the field. Click here to read about a recent study evaluating the effect of tonsillectomy on psoriasis patients, and why the surgery might help with disease symptoms.
Two other U-M clinician-scientists, Santhi Ganesh, M.D., and Adam Lauring, M.D., Ph.D., also received the three-year development awards. Click here to read the entire Doris Duke Charitable Foundation press release.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
PBS series features institute director on Jan. 18
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features Taubman Institute Director Eva Feldman, M.D., Ph.D. and her landmark ALS stem cell trial in the Jan. 18 episode.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.